Table 1

Quantitative counts of the percentage of cells in sections and cytospots of primary uveal melanoma, and in sections of metastasised uveal melanoma reacting with monoclonal antibodies directed against HLA class I antigens

Cell linePrimary tumourMetastases
Antigen MAb 92-1 Part 1 Part 2 Adrenal gland Skin Liver Heart
Mel Ass Ag NKI-beteb5/+5/+5/++5/+5/++5/+++5/+++
HLA-A,B,CW6/325/++5/++5/++5/+5/++5/+5/++
b2-micBBM15/+++5/++5/++5/+5/++5/+5/++
A locusHCA25/+++3/+5/+5/+4/+3/+5/+
A2MA2.15/++5/++5/++5/++3/+1/++5/++
A3GAP-A35/++5/++5/++5/+3/+2/+4/+
B locusHC105/++3/+5/++3/+4/+4/+5/++
Bw4116 5 283/+1/++1/+++2/++1/++2/++1/++
DPB7/21.202/++2/+++2/++2/++2/++2/+++
DQSPV-L302/++2/++2/++2/+++3/+++2/+++
DRB811.202/++2/++2/++2/++1/+2/++
  • Melanoma associated antigen, as determined with MAb NKI-beteb.

  • Score: 1 = less than 5% of cells staining positive; 2 = 5–25%; 3 = 26–50%; 4 = 51–75%; 5 = 76–100%.

  • Intensity of staining: + = slight, ++ = moderate, and +++ = strong staining.